Literature DB >> 3622565

A rapid method for the evaluation of diagnostic radioaerosol delivery systems.

P Phipps, P Borham, I Gonda, D Bailey, G Bautovich, S Anderson.   

Abstract

The effective delivery (ED) in MBq/min of a 100 MBq/ml nebuliser solution was defined as the rate of delivery of droplets in the respirable size range (aerodynamic diameter below 3.3 micron) to the mouthpiece of the aerosol delivery system (ADS). Wasted delivery (WD) was defined as the rate of delivery of droplets above 3.3 microns. ED and WD were measured on four types of commercially available ADS. The aerosols were sampled at the mouthpiece of each system and droplet size distribution measured with a seven stage cascade impactor. The effect of ambient air humidity on the droplet size produced by the Cadema delivery system was also evaluated. The ED values ranged from 6 to 15 MBq/min and WD values from 0.01 to 15 MBq/min. Two ADS produced low ED and WD values (6.1-9.0 and 0.01-0.07 MBq/min, respectively) due to a low output, while another produced higher ED and WD values [11.3 +/- 0.2 (SD) and 15.4 +/- 0.5 (SD) MBq/min, respectively] due to a larger droplet size. The Cadema delivery system gave the optimum characteristic of high ED [13.9 +/- 0.8 (SD) MBq/min] and low WD [1.24 +/- 0.61 (SD) MBq/min] values. The mass median aerodynamic diameter (MMAD) of the Cadema ADS fell by 22% (P less than 0.01) as the ambient dilution air was dried from a high relative humidity (RH) (88%-100%) to a low RH (12%-17%). The variability of both MMAD and geometric standard deviation (sigma g) was increased with dry dilution air (P less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622565     DOI: 10.1007/bf00256488

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

1.  Properties of aerosols produced with three nebulizers.

Authors:  G A Ferron; K F Kerrebijn; J Weber
Journal:  Am Rev Respir Dis       Date:  1976-11

2.  Factors affecting the 'alveolar deposition' of 5 microns inhaled particles in healthy subjects.

Authors:  J E Agnew; D Pavia; S W Clarke
Journal:  Clin Phys Physiol Meas       Date:  1985-02

3.  Physical properties of aerosols produced by several jet- and ultrasonic nebulizers.

Authors:  P J Sterk; A Plomp; J F van de Vate; P H Quanjer
Journal:  Bull Eur Physiopathol Respir       Date:  1984 Jan-Feb

4.  The preferential deposition of inhaled isoproterenol and propranolol in asthmatic patients.

Authors:  R E Ruffin; M B Dolovich; F A Oldenburg; M T Newhouse
Journal:  Chest       Date:  1981-12       Impact factor: 9.410

5.  Relationship between regional ventilation and aerosol deposition in tidal breathing.

Authors:  M Trajan; J W Logus; E G Enns; S F Man
Journal:  Am Rev Respir Dis       Date:  1984-07

6.  Comparison of lung deposition of a solution after nebulization by three commonly used portable nebulizers.

Authors:  R A Foulds; L O Smithuis
Journal:  Pharm Weekbl Sci       Date:  1983-04-29

7.  Improved radioaerosol administration system for routine inhalation lung imaging.

Authors:  M Hayes; G V Taplin; S K Chopra; D E Knox; D Elam
Journal:  Radiology       Date:  1979-04       Impact factor: 11.105

8.  Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation.

Authors:  G Ryan; M B Dolovich; G Obminski; D W Cockcroft; E Juniper; F E Hargreave; M T Newhouse
Journal:  J Allergy Clin Immunol       Date:  1981-02       Impact factor: 10.793

9.  Tc-99m-DTPA aerosol and radioactive gases compared as adjuncts to perfusion scintigraphy in patients with suspected pulmonary embolism.

Authors:  P O Alderson; D R Biello; A Gottschalk; P B Hoffer; S A Kroop; M E Lee; L Ramanna; B A Siegel; A D Waxman
Journal:  Radiology       Date:  1984-11       Impact factor: 11.105

10.  Early detection of chronic obstructive pulmonary disease using radionuclide lung-imaging procedures.

Authors:  G V Taplin; D P Tashkin; S K Chopra; O E Anselmi; D Elam; B Calvarese; A Coulson; R Detels; S N Rokaw
Journal:  Chest       Date:  1977-05       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.